Back to Search
Start Over
Drug companies are fined more than £260m for overcharging NHS for hydrocortisone pills
Drug companies are fined more than £260m for overcharging NHS for hydrocortisone pills
- Source :
- BMJ (Clinical research ed.). 374
- Publication Year :
- 2021
-
Abstract
- The Competition and Markets Authority has fined drug companies over £260m (€305m; $360m) for inflating the price of hydrocortisone tablets by more than 10 000%. The rising costs meant that the amount the NHS paid for a single pack of 10 mg hydrocortisone tablets rose from 70 p in April 2008 to £88 by March 2016, the CMA said.1 For the 20 mg version the price rose from £1.07 to £102.74 a pack over the same period. Before April 2008 the NHS was spending around £500 000 a year on hydrocortisone tablets, the CMA said. This had risen to …
Details
- ISSN :
- 17561833
- Volume :
- 374
- Database :
- OpenAIRE
- Journal :
- BMJ (Clinical research ed.)
- Accession number :
- edsair.doi.dedup.....96930e5a4fb1b18a7d67efff9981c7a8